Samsca and Blopress drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Samsca (tolvaptan) and Blopress (candesartan cilexetil). Common drug interactions include hypernatraemia among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Samsca and Blopress. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.

What is Samsca?

Samsca has active ingredients of tolvaptan. eHealthMe is studying from 8,139 Samsca users. Check the latest studies of Samsca.

What is Blopress?

Blopress has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 7,479 Blopress users. Check the latest studies of Blopress.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

66 people who take Samsca and Blopress together, and have interactions are studied.

Samsca and Blopress drug interactions.

What are the common drug interactions of Samsca and Blopress, by gender? *:

female:

  1. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Arthralgia (joint pain)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Dyspnoea (difficult or laboured respiration)
  7. Emotional distress
  8. Fear
  9. General physical health deterioration (weak health status)
  10. Injury

male:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Folliculitis (infection of hair root)
  4. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Haemophilic arthropathy (permanent joint disease)
  7. Hepatitis c
  8. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  9. Hypertriglyceridaemia (excess of triglycerides in the blood)
  10. Oesophageal candidiasis (fungal infection of oesophagus)

What are the common drug interactions of Samsca and Blopress, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Altered state of consciousness (altered state of mind)
  3. Cholangitis acute (rapid infection of bile duct)
  4. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  5. Haematuria (presence of blood in urine)
  6. Pyrexia (fever)
  7. Renal impairment (severely reduced kidney function)

40-49:

  1. Cerebral infarction (less blood supply to brain resulting tissue damage)
  2. Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Haemoglobin decreased
  5. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  6. Abscess limb (limb infection)
  7. Anaemia (lack of blood)
  8. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
  9. C-reactive protein increased
  10. Cellulitis (infection under the skin)

50-59:

  1. Right ventricular failure (right half of the heart fails to work)
  2. Thirst
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Uterine cancer
  5. Uterine haemorrhage (uterine bleeding)
  6. White blood cell count increased
  7. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  8. Hypokalaemia (low potassium)
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Oedema due to renal disease (fluid collection in tissue due to kidney disease)

60+:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Renal impairment (severely reduced kidney function)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Diarrhoea
  6. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Infusion site erythema (reddening of the skin at infusion site)
  9. Infusion site induration
  10. Infusion site pain

What are the existing conditions these people have? *

  1. Cardiac Failure: 22 people, 33.33%
  2. Fluid Retention (an abnormal accumulation of fluid in the blood): 12 people, 18.18%
  3. Mycobacterium Avium Complex Infection: 7 people, 10.61%
  4. Hiv Infection: 7 people, 10.61%
  5. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 9.09%
  6. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 7.58%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 6.06%
  8. Haemophilic Arthropathy (permanent joint disease): 4 people, 6.06%
  9. Enlarged Prostate: 4 people, 6.06%
  10. Cardiac Failure Congestive: 4 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Samsca and Blopress?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Samsca and Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Samsca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Blopress:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Samsca and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Blopress and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tolvaptan and candesartan cilexetil (the active ingredients of Samsca and Blopress, respectively), and Samsca and Blopress (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: